Dana-Farber Cancer Institute

Amount
$100000
Date
December 2015

Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital Medical Center

Amount
$100000
Date
December 2015

An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)

Memorial Sloan Kettering Cancer Center

Amount
$99880
Date
December 2015

Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models

Baylor College of Medicine/Texas Children's Hospital

Amount
$200000
Date
December 2015

Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models

Children's National Health System and Children's Research Institute

Amount
$125000
Date
December 2015

Comprehensive Molecular?Based Cross?Species Comparison of DIPG Biology

Boston Children's Hospital

Amount
$110000
Date
December 2015

Enabling epigenetic therapies by exploring DIPG chromatin sensitivities

UCL Institute of Child Health

Amount
$200000
Date
December 2015

Towards T-cell based immunotherapy for DIPG

Dana Farber Cancer Institute

Amount
$100,000
Date
December 2015

Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma